These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24528518)

  • 21. Update on diagnostic and treatment of uncomplicated and complicated malaria in adults and selected vulnerable populations.
    Botha P; Bottieau E; Uthman O; Obike U; Nachega JB
    Infect Disord Drug Targets; 2013 Aug; 13(4):278-91. PubMed ID: 24387665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique.
    Saracino A; Nacarapa EA; da Costa Massinga EA; Martinelli D; Scacchetti M; de Oliveira C; Antonich A; Galloni D; Ferro JJ; Macome CA
    Malar J; 2012 Jul; 11():241. PubMed ID: 22835018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection.
    Adegbola A; Abutaima R; Olagunju A; Ijarotimi O; Siccardi M; Owen A; Soyinka J; Bolaji O
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of HIV-infected pregnant patients in malaria-endemic areas: therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents.
    Okereke CS
    Clin Ther; 1999 Sep; 21(9):1456-96; discussion 1427-8. PubMed ID: 10509844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV and malaria co-infection: interactions and consequences of chemotherapy.
    Skinner-Adams TS; McCarthy JS; Gardiner DL; Andrews KT
    Trends Parasitol; 2008 Jun; 24(6):264-71. PubMed ID: 18456554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    Ottichilo RK; Polyak CS; Guyah B; Singa B; Nyataya J; Yuhas K; John-Stewart G; Waitumbi JN
    J Infect Dis; 2017 Jan; 215(1):88-94. PubMed ID: 28077587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro.
    Mishra LC; Bhattacharya A; Sharma M; Bhasin VK
    Am J Trop Med Hyg; 2010 Jan; 82(1):148-50. PubMed ID: 20065012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
    Kakuda TN; DeMasi R; van Delft Y; Mohammed P
    HIV Med; 2013 Aug; 14(7):421-9. PubMed ID: 23441978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
    Gignoux E; Azman AS; de Smet M; Azuma P; Massaquoi M; Job D; Tiffany A; Petrucci R; Sterk E; Potet J; Suzuki M; Kurth A; Cannas A; Bocquin A; Strecker T; Logue C; Pottage T; Yue C; Cabrol JC; Serafini M; Ciglenecki I
    N Engl J Med; 2016 Jan; 374(1):23-32. PubMed ID: 26735991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.
    Kredo T; Mauff K; Van der Walt JS; Wiesner L; Maartens G; Cohen K; Smith P; Barnes KI
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5616-23. PubMed ID: 21947399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei.
    Abiodun OO; Akinbo J; Ojurongbe O
    J Chemother; 2015 Feb; 27(1):25-8. PubMed ID: 24621166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of HIV infection on malaria and therapeutic implications: a systematic review.
    Flateau C; Le Loup G; Pialoux G
    Lancet Infect Dis; 2011 Jul; 11(7):541-56. PubMed ID: 21700241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060.
    Hobbs CV; Gabriel EE; Kamthunzi P; Tegha G; Tauzie J; Petzold E; Barlow-Mosha L; Chi BH; Li Y; Ilmet T; Kirmse B; Neal J; Parikh S; Deygoo N; Jean Philippe P; Mofenson L; Prescott W; Chen J; Musoke P; Palumbo P; Duffy PE; Borkowsky W;
    PLoS One; 2016; 11(12):e0165140. PubMed ID: 27936233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.
    Li X; He Z; Chen L; Li Y; Li Q; Zhao S; Tao Z; Hu W; Qin L; Chen X
    Parasitol Res; 2011 Dec; 109(6):1519-24. PubMed ID: 21537980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa.
    Fehintola FA; Akinyinka OO; Adewole IF; Maponga CC; Ma Q; Morse GD
    Curr Drug Metab; 2011 Jan; 12(1):51-6. PubMed ID: 21222586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
    Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
    PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
    Maganda BA; Minzi OM; Ngaimisi E; Kamuhabwa AA; Aklillu E
    Pharmacogenomics J; 2016 Feb; 16(1):88-95. PubMed ID: 25963334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.
    Mangesho PE; Reynolds J; Lemnge M; Vestergaard LS; Chandler CI
    Malar J; 2014 Dec; 13():491. PubMed ID: 25495956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa.
    Kamya MR; Byakika-Kibwika P; Gasasira AF; Havlir D; Rosenthal PJ; Dorsey G; Achan J
    Future Virol; 2012; 7(7):699-708. PubMed ID: 23293660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
    Scarsi KK; Fehintola FA; Ma Q; Aweeka FT; Darin KM; Morse GD; Akinola IT; Adedeji WA; Lindegardh N; Tarning J; Ojengbede O; Adewole IF; Taiwo B; Murphy RL; Akinyinka OO; Parikh S
    J Antimicrob Chemother; 2014 May; 69(5):1370-6. PubMed ID: 24446424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.